Literature DB >> 15882607

CCL3L1 dose and HIV-1 susceptibility.

Charles R Mackay1.   

Abstract

Several genetic factors influence HIV-1 susceptibility or AIDS disease progression. A recent study reported on what could be a particularly important genetic determinant for HIV-1 susceptibility and disease progression: copy number of a chemokine gene termed CCL3L1. Individuals with low copy numbers of the gene, relative to their ethnic background, were associated with markedly enhanced HIV-1/AIDS susceptibility. These findings define an important new genetic determinant of HIV-1 susceptibility and further emphasize the importance of the chemokine system, either as elements that inhibit HIV-1 infection or that modulate antiviral immune responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882607     DOI: 10.1016/j.molmed.2005.03.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  6 in total

Review 1.  Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders.

Authors:  Suman Jayadev; Gwenn A Garden
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-17       Impact factor: 4.147

2.  Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.

Authors:  H-F Dong; K Wigmore; M N Carrington; M Dean; J A Turpin; O M Z Howard
Journal:  Genes Immun       Date:  2005-10       Impact factor: 2.676

Review 3.  Copy number variation in the human genome and its implication in autoimmunity.

Authors:  H Schaschl; T J Aitman; T J Vyse
Journal:  Clin Exp Immunol       Date:  2009-02-11       Impact factor: 4.330

4.  CCL3L1 copy number variation and susceptibility to HIV-1 infection: a meta-analysis.

Authors:  SiJie Liu; Lei Yao; DongLin Ding; HuanZhang Zhu
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

5.  Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.

Authors:  Tetsuya Adachi; Reiko Tanaka; Akira Kodama; Mineki Saito; Yoshiaki Takahashi; Aftab A Ansari; Yuetsu Tanaka
Journal:  Retrovirology       Date:  2011-10-22       Impact factor: 4.602

Review 6.  Genetic Variations in Vesicoureteral Reflux Sequelae.

Authors:  David S Hains; Andrew L Schwaderer
Journal:  Pathogens       Date:  2016-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.